Wilk Technologies Ltd.

Investor Presentation • Jul 12, 2023

Wilk – The Revolution of Milk

Forward Looking Statement

This presentation was prepared by Wilk Technologies Ltd. (the "Company") and is given to you only for the provision of concise information for the sake of convenience and may not be copied or distributed to any other person. The data and information included in this presentation should not be interpreted as advice and should not be relied on for any purpose. Such data and information should not be copied or used except as expressly permitted in writing.

This presentation does not purport to be comprehensive or to contain any and all information which might be relevant in connection with the making of a decision on an investment in securities of the Company. No explicit or implicit representation or undertaking is given by any person regarding the accuracy or integrity of any information included in this presentation. In particular, no representation or undertaking is given regarding the realization or reasonableness of any forecasts regarding the future chances of the Company. To obtain a full picture of the activities of the Company and the risks entailed thereby, see the full immediate and periodic reports filed in connection with the Company with the Israel Securities Authority and the Tel Aviv Stock Exchange Ltd., including warnings regarding forward-looking information, as defined in the Securities Law, 5728-1968, included therein. The forward-looking information in the presentation may not materialize, in whole or in part, or may materialize differently than expected, or may be affected by factors that cannot be assessed in advance. For the avoidance of doubt, it is clarified that the Company does not undertake to update and/or modify the information included in the presentation to reflect events and/or circumstances occurring after the date of preparation of the presentation. This presentation is not an offer or invitation to buy or subscribe to any securities. This presentation and anything contained herein are not a basis for any contract or undertaking and are not to be relied upon in such context. The information provided in the presentation is not a basis for the making of any investment decision, nor a recommendation or an opinion, nor a substitute for the discretion of a potential investor.

Company Highlights

10+ Years of proprietary research

15 Full-time employees

6 Patents granted

100% Farm-free

~\$14 m Capital raised to date

We replicate the milk-producing process to create 100% real milk components in laboratory settings.

We have developed the first yogurt in the world made with cell-cultured bovine milk lipids.

We entered into a Strategic partnership with the Central Bottling Company

Global food and beverage giant Danone led a significant investment round, committing to supporting innovative, sustainable businesses in the industry.

2020 Founded in Israel

5 SDGs compliance

2 Human clinical trials

100% REAL MILK

2026 Expected commercialization

Highly Experienced Management Team MANAGEMENT

Tomer Aizen

CEO

15+ years of experience in commercial managerial positions in the healthcare field. Skilled in creating value through multidimensional actions. Holds a BA in Law and is a certified Lawyer.

Zohar Barbash, PhD

CTO

Dr. Barbash holds PhD in Molecular genetics from Tel Aviv university and a postdoc at the National cancer institute, Bethesda MD, US, in molecular and cellular biology. Zohar has extensive experience as an executive, leading complex projects in various areas of research and product development.

Asaf Abramov, Adv.

Business Development

Leverages his legal background to drive growth, nurture partnerships, and navigate regulatory challenges. Asaf's unique blend of law and business acumen sets our organization apart in a competitive landscape.

ADVISORS

Yael Ravhon

Advisor Former founder and CEO of Abbott Israel. 20+ years of

experience in the field of pharma, medical nutrition and baby food.

Prof. Bruce German

Advisor

Prof. Nurit Argov-Argaman

15+ years of specialization in the study of metabolic control in milk compositions. Senior Lecturer at the Hebrew University of Jerusalem. Postdoctoral Fellowship in Food Science and Technology.

CSO

Top global KOL in the scientific field of milk and breast milk. Respected advisor to various and globally leading dairy companies.

Prof. Ronit Lubetzky

Moran Attar, CPA

tech industries; including TASE, Nasdaq and LSE listed companies. Hold an M.A. in

15 years of experience as a financial advisor and accountant- in the pharma, retail, high-tech and food-

CFO

Accounting.

Advisor

Director of the Pediatrics Department at Tel Aviv Medical Center. Awarded scientist with specific research area on human milk composition in various maternal and neonatal settings.

Milk is Unique

Evolution

Milk is the only whole food that evolved solely to provide complete nutrition to mammals.

Complex

Contains over 2000 micro and macronutrients which support survival and development.

Unique

Its unique delivery system enables the most efficient mechanism to absorb nutrients

Challenges in the Traditional Dairy Industry

Boom in Consumption

• Expected global population of ~10 billion by 2050¹
• 56% growth in global food consumption by 2050 versus 2010¹

The Dairy Industry Environmental Effects

• 1L of milk requires 1,000L of water²
• 4% of total global anthropogenic GHG emissions³

Consumer Shift For Eco-Friendly Alternatives

• Growing consumer concern regarding animal welfare⁴
• Rising demand for sustainably farmed and animal-free goods⁴

Source: Company Information. World Resources Institute ("WRI"), Food for Water, Food and Agriculture Organization of the United Nations ("FAO"), Arizton. | (1) As per WRI; (2) As per Food for Water; (3) As per FAO; (4) As per Arizton.

Challenges for Babies

Limited Proportion of Babies Get Breastfed

• World Health Organization recommends exclusive breastfeeding for the first 6 months¹
• Less than half of babies are breastfed for that entire period¹

Preterm Newborns Require Breast Milk to Survive

• 10% of babies are born preterm²
• Potentially fatal consequences²

Limited Availability of Safe Human Breast Milk

• Increased unregulated sales of human milk through social marketplaces³
• Overall nutritional inferiority of infant formulas³

Source: Company Information. World Health Organization, Centers for Disease Control and Prevention ("CDC"), Food and Drug Administration ("FDA"). | (1) As per World Health Organization; (2) As per CDC; (3) As per FDA.

Our Products

Bovine Milk Fat Human Milk Fat

The Technology

Wilk's Technology: Cell-Based Milk

Substantial Total Addressable Market Opportunity

Attractive opportunity to disrupt multiple end markets

Go-to-market Strategy

Strategic Partnerships

The Central Bottling Company

• We entered into a strategic partnership with Tara a subsidiary of the Central Bottling Company (Coca-Cola Israel), in August 2021.
• Tara is Israel's 2 nd largest milk processor and the leading player in South Africa's dairy market.
• Ongoing collaboration with Tara's scientific and food-tech experts.
• Mutually exclusive rights in bovine milk ingredients, covering Israel and South Africa.
• CBC invested \$1.5M in WILK, with an option for further financing.

Danone

• As of May 2023, we've succeeded to raise extraordinary investment , revolutionizing our approach in the industry.
• Danone invested \$2M in WILK.

Achievements

So far Wilk raised over \$14M that served establishing state-of-the-art R&D activities, supported by lean management operations

• Spin out from Academia
• Listing on Tel Aviv Stock Exchange
• 625 sqm of R&D facilities and offices
• Unique combination of talents
• Strong IP portfolio (unique know-how and six granted patents)
• Strategic partnership with Coca Cola Israel
• Investment from Danone
• Successful expression of major milk compounds
• World's first concept hybrid dairy product with cell-based milk ingredients
• Global recognition in press and professional forums
• Warm interests from major industrial players

* exchange rate USD/NIS 3.6

Thanks for your Attention